Ignite Creation Date:
2024-05-05 @ 9:36 AM
Last Modification Date:
2024-10-26 @ 9:02 AM
Study NCT ID:
NCT00002155
Status:
COMPLETED
Last Update Posted:
2005-06-24
First Post:
1999-11-02
Brief Title:
A Six-Month Safety and Antiviral Study in HIV-1 Seropositive AZT-Experienced Patients With CD4 Counts Less Than or Equal to 50 Cellsmm3 to Evaluate MK-639 Alone Versus Zidovudine AZT and 3TC Versus the Combination of MK-639 With AZT3TC
Sponsor:
Merck Sharp Dohme LLC
Organization:
NIH AIDS Clinical Trials Information Service
Key Dates - Follows AllAPIJSON File Order
Start Date:
None
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
None
Completion Date Type:
None
First Submit Date:
1999-11-02
First Submit QC Date:
August 30 2001
Study First Post Date:
2001-08-31
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2005-06-23
Last Update Post Date:
2005-06-24
Last Update Post Date Type:
ESTIMATED